These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liver transplantation for status 1: the consequences of good intentions. McDiarmid SV, Goodrich NP, Harper AM, Merion RM. Liver Transpl; 2007 May; 13(5):699-707. PubMed ID: 17457930 [Abstract] [Full Text] [Related]
4. Liver transplantation in New Zealand: the first four years. Gane E, McCall J, Streat S, Gunn K, Yeong ML, Fitt S, Keenan D, Munn S. N Z Med J; 2002 Aug 09; 115(1159):U120. PubMed ID: 12362165 [Abstract] [Full Text] [Related]
5. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. Arch Surg; 2007 Nov 09; 142(11):1079-85. PubMed ID: 18025337 [Abstract] [Full Text] [Related]
6. Deaths on the liver transplant waiting list: an analysis of competing risks. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Hepatology; 2006 Feb 09; 43(2):345-51. PubMed ID: 16440361 [Abstract] [Full Text] [Related]
7. Overview of the MELD score and the UNOS adult liver allocation system. Martin AP, Bartels M, Hauss J, Fangmann J. Transplant Proc; 2007 Dec 09; 39(10):3169-74. PubMed ID: 18089345 [Abstract] [Full Text] [Related]
8. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores. Teixeira AC, Souza FF, Sankarankutty AK, Martinelli AL, Castro E Silva O. Transplant Proc; 2007 Mar 09; 39(2):387-9. PubMed ID: 17362738 [Abstract] [Full Text] [Related]
9. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival? Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA. Transpl Int; 2006 Apr 09; 19(4):275-81. PubMed ID: 16573542 [Abstract] [Full Text] [Related]
12. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O, Perrella A, Arenga G. Transplant Proc; 2008 Apr 09; 40(6):1906-9. PubMed ID: 18675085 [Abstract] [Full Text] [Related]
13. Variant techniques for liver transplantation in pediatric programs. Burgos L, Hernández F, Barrena S, Andres AM, Encinas JL, Leal N, Gamez M, Murcia J, Jara P, Lopez-Santamaria M, Tovar JA. Eur J Pediatr Surg; 2008 Dec 09; 18(6):372-4. PubMed ID: 19039737 [Abstract] [Full Text] [Related]
16. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R. Isr Med Assoc J; 2006 Sep 09; 8(9):605-9. PubMed ID: 17058408 [Abstract] [Full Text] [Related]
20. Morbidity and mortality of children with chronic liver diseases who were listed for liver transplantation in Iran. Dehghani SM, Gholami S, Bahador A, Nikeghbalian S, Salahi H, Imanieh MH, Haghighat M, Davari HR, Mehrabani D, Malek-Hosseini SA. Pediatr Transplant; 2007 Feb 09; 11(1):21-3. PubMed ID: 17239119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]